Pre-treatment/post- treatment variable | Variable | Treatment outcome | n | Minimum | Maximum | Mean | SD |
---|---|---|---|---|---|---|---|
Pre-treatment | Age | P1P2 | 2001 | 17 | 86 | 37.86 | 13.36 |
P1N2 | 440 | 18 | 88 | 36.67 | 13.42 | ||
N1P2 | 222 | 17 | 83 | 40.17 | 14.97 | ||
N1N2 | 1728 | 12 | 100 | 38.92 | 12.51 | ||
Pre-treatment | PHQ9 1st score | P1P2 | 2001 | 0 | 27 | 11.7 | 6.3 |
P1N2 | 440 | 1 | 27 | 13.0 | 5.8 | ||
N1P2 | 222 | 0 | 27 | 15.9 | 5.3 | ||
N1N2 | 1729 | 0 | 27 | 18.3 | 5.3 | ||
Pre-treatment | GAD-7 1st score | P1P2 | 2000 | 0 | 21 | 10.6 | 5.5 |
P1N2 | 439 | 0 | 21 | 13.6 | 4.7 | ||
N1P2 | 222 | 0 | 21 | 11.1 | 5.4 | ||
N1N2 | 1729 | 0 | 21 | 15.6 | 4.4 | ||
Pre-treatment | IMD | P1P2 | 1971 | 1.4 | 61.4 | 26.39 | 11.72 |
P1N2 | 426 | 2.4 | 61.4 | 26.69 | 12.04 | ||
N1P2 | 217 | 4.0 | 61.4 | 27.38 | 12.79 | ||
N1N2 | 1702 | 3.1 | 69.7 | 29.94 | 12.66 | ||
Post-treatment | Length of treatment (days) | P1P2 | 1825 | 3 | 571 | 121.64 | 78.15 |
P1N2 | 371 | 5 | 510 | 130.18 | 91.35 | ||
N1P2 | 196 | 1 | 454 | 108.57 | 80.67 | ||
N1N2 | 1448 | 1 | 482 | 108.94 | 79.06 | ||
Post-treatment | Number of sessions not attended | P1P2 | 2001 | 0 | 9 | 0.55 | 0.98 |
P1N2 | 440 | 0 | 7 | 0.66 | 1.07 | ||
N1P2 | 222 | 0 | 6 | 0.85 | 1.11 | ||
N1N2 | 1729 | 0 | 12 | 0.97 | 1.31 | ||
Post-treatment | Number of sessions attended | P1P2 | 2001 | 1 | 32 | 8.01 | 5.13 |
P1N2 | 440 | 1 | 32 | 7.14 | 5.54 | ||
N1P2 | 222 | 1 | 28 | 6.19 | 4.76 | ||
N1N2 | 1729 | 1 | 33 | 6.41 | 5.18 |
GAD-7, Generalised Anxiety Disorder-7; IMD, Index of Multiple Deprivation; N1P2, negative PHQ-9, positive GAD-7; N1N2, negative PHQ-9, negative GAD-7; P1P2, positive PHQ-9, positive GAD-7; P1N2, positive PHQ-9, negative GAD-7; PHQ9, Patient Health Questionnaire-9.